吉利德科学 GILD 深 沪
等待开盘 05-11 09:30:00 美东时间
131.19
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 131.19
- 总市值 1.65亿
- 52周最高 157.29
- 市盈率 静 26.60
- 换手率 0.00%
- 52周最低 102.84
- 委 比 0.00%
- 总股本 0.01亿
- 历史最高 157.29
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.195
- 每 手 1
- 风险率 13.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Nasdaq Tops 29,000 Records, Micron Soars 13%: Stock Market Today
Nasdaq jumps 1.6% to record highs Friday as semiconductor rally and stronger-than-expected April payrolls overshadow ongoing Strait of Hormuz tensions.
05-09 01:36
Kailera Therapeutics' Strong IPO Validates "NewCo" Strategy
A company set up to develop Hengrui Pharma's weight-loss drugs has made a stron...
04-24 00:08
Gilead Sciences Receives All Required Regulatory Approvals To Acquire Arcellx At $115/Share
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that all required regulatory approvals have been obtained for its previously announced acquisition of Arcellx and that Gilead has extended the expiration of the tender
04-17 20:31
Gilead Expands Tempus AI Partnership To Boost Oncology Pipeline
Gilead expands Tempus AI deal and licenses Kymera's KT-200, advancing oncology pipeline with data, analytics and drug development.
04-10 01:14
Gilead Acquisition Spree Continues With $3 Billion Tubulis Deal
Gilead shares dip after $3.15 billion Tubulis deal adds ADC asset, as multiple acquisitions reshape oncology and autoimmune pipeline outlook.
04-08 00:06
Gilead Powers Up Its Inflammation Pipeline With Over $1.5 Billion Acquisition
Gilead to acquire Ouro Medicines for $1.675 billion, explores Galapagos collaboration, outlines cost-sharing and royalty terms.
03-25 01:58
P/E Ratio Insights for Gilead Sciences
In the current market session, Gilead Sciences Inc. (NASDAQ:GILD) stock price i...
02-28 06:00
Gilead Buys Arcellx To Fast-Track Next-Gen Myeloma Drug
Gilead Sciences to acquire Arcellx for $7.8B, gaining full control of promising CAR T-cell therapy for cancer.
02-23 20:51
